キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/02/10 | 1,875 | 2,005 | 1,815 | 2,000 | +63 | +3.3% | 3,265,400 |
| 2023/02/09 | 1,998 | 2,028 | 1,894 | 1,937 | -79 | -3.9% | 3,893,800 |
| 2023/02/08 | 1,925 | 2,068 | 1,890 | 2,016 | +108 | +5.7% | 7,920,000 |
| 2023/02/07 | 1,712 | 1,984 | 1,703 | 1,908 | +174 | +10% | 8,827,600 |
| 2023/02/06 | 1,680 | 1,792 | 1,660 | 1,734 | +37 | +2.2% | 2,128,400 |
| 2023/02/03 | 1,833 | 1,837 | 1,681 | 1,697 | -42 | -2.4% | 2,744,900 |
| 2023/02/02 | 1,750 | 1,819 | 1,654 | 1,739 | -47 | -2.6% | 4,046,800 |
| 2023/02/01 | 1,756 | 1,933 | 1,752 | 1,786 | -8 | -0.4% | 11,867,900 |
| 2023/01/31 | 1,543 | 1,878 | 1,512 | 1,794 | +262 | +17.1% | 17,460,400 |
| 2023/01/30 | 1,382 | 1,532 | 1,373 | 1,532 | +300 | +24.4% | 6,844,600 |
| 2023/01/27 | 1,245 | 1,255 | 1,222 | 1,232 | -19 | -1.5% | 555,700 |
| 2023/01/26 | 1,266 | 1,283 | 1,226 | 1,251 | -1 | -0.1% | 839,900 |
| 2023/01/25 | 1,269 | 1,272 | 1,231 | 1,252 | -9 | -0.7% | 879,600 |
| 2023/01/24 | 1,274 | 1,319 | 1,251 | 1,261 | -1 | -0.1% | 1,130,100 |
| 2023/01/23 | 1,352 | 1,356 | 1,255 | 1,262 | -89 | -6.6% | 2,358,300 |
| 2023/01/20 | 1,220 | 1,370 | 1,219 | 1,351 | +115 | +9.3% | 2,697,600 |
| 2023/01/19 | 1,229 | 1,255 | 1,205 | 1,236 | -4 | -0.3% | 822,000 |
| 2023/01/18 | 1,246 | 1,287 | 1,220 | 1,240 | -20 | -1.6% | 1,255,100 |
| 2023/01/17 | 1,216 | 1,262 | 1,216 | 1,260 | +35 | +2.9% | 823,000 |
| 2023/01/16 | 1,214 | 1,246 | 1,193 | 1,225 | -5 | -0.4% | 913,400 |
| 2023/01/13 | 1,310 | 1,322 | 1,222 | 1,230 | -88 | -6.7% | 1,368,000 |
| 2023/01/12 | 1,360 | 1,360 | 1,292 | 1,318 | -36 | -2.7% | 1,004,600 |
| 2023/01/11 | 1,301 | 1,368 | 1,296 | 1,354 | +44 | +3.4% | 1,888,400 |
| 2023/01/10 | 1,225 | 1,325 | 1,209 | 1,310 | +85 | +6.9% | 1,585,300 |
| 2023/01/06 | 1,249 | 1,284 | 1,202 | 1,225 | -32 | -2.5% | 1,672,300 |
| 2023/01/05 | 1,157 | 1,260 | 1,156 | 1,257 | +83 | +7.1% | 2,132,000 |
| 2023/01/04 | 1,140 | 1,194 | 1,121 | 1,174 | +6 | +0.5% | 1,511,700 |
| 2022/12/30 | 1,160 | 1,230 | 1,114 | 1,168 | +28 | +2.5% | 2,477,400 |
| 2022/12/29 | 1,202 | 1,223 | 1,125 | 1,140 | -46 | -3.9% | 2,096,100 |
| 2022/12/28 | 1,170 | 1,263 | 1,143 | 1,186 | +22 | +1.9% | 2,919,000 |
| 2022/12/27 | 1,186 | 1,240 | 1,143 | 1,164 | -39 | -3.2% | 2,265,800 |
| 2022/12/26 | 1,312 | 1,319 | 1,115 | 1,203 | -151 | -11.2% | 2,958,100 |
| 2022/12/23 | 1,255 | 1,389 | 1,222 | 1,354 | +104 | +8.3% | 4,107,300 |
| 2022/12/22 | 1,320 | 1,333 | 1,224 | 1,250 | -75 | -5.7% | 2,671,900 |
| 2022/12/21 | 1,371 | 1,400 | 1,310 | 1,325 | -34 | -2.5% | 1,407,900 |
| 2022/12/20 | 1,487 | 1,507 | 1,304 | 1,359 | -128 | -8.6% | 3,164,300 |
| 2022/12/19 | 1,550 | 1,599 | 1,467 | 1,487 | -39 | -2.6% | 2,985,600 |
| 2022/12/16 | 1,370 | 1,533 | 1,353 | 1,526 | +126 | +9% | 5,346,900 |
| 2022/12/15 | 1,516 | 1,522 | 1,351 | 1,400 | -94 | -6.3% | 4,031,100 |
| 2022/12/14 | 1,529 | 1,567 | 1,468 | 1,494 | -24 | -1.6% | 4,544,500 |
| 2022/12/13 | 1,379 | 1,518 | 1,371 | 1,518 | +109 | +7.7% | 5,881,500 |
| 2022/12/12 | 1,311 | 1,460 | 1,290 | 1,409 | +104 | +8% | 8,131,200 |
| 2022/12/09 | 1,241 | 1,336 | 1,221 | 1,305 | +59 | +4.7% | 3,833,700 |
| 2022/12/08 | 1,333 | 1,342 | 1,240 | 1,246 | -98 | -7.3% | 3,896,100 |
| 2022/12/07 | 1,226 | 1,345 | 1,204 | 1,344 | +143 | +11.9% | 7,397,600 |
| 2022/12/06 | 1,110 | 1,226 | 1,069 | 1,201 | +67 | +5.9% | 3,257,100 |
| 2022/12/05 | 1,157 | 1,198 | 1,113 | 1,134 | -48 | -4.1% | 2,344,600 |
| 2022/12/02 | 1,150 | 1,258 | 1,136 | 1,182 | +81 | +7.4% | 6,682,100 |
| 2022/12/01 | 1,100 | 1,167 | 1,027 | 1,101 | +35 | +3.3% | 4,754,200 |
| 2022/11/30 | 1,078 | 1,129 | 1,065 | 1,066 | -72 | -6.3% | 3,029,700 |
401～
450
件表示中 / 3548件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 112,400円 | - | - | 0.00% | - | 8.79倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| 扶桑薬 | 226,000円 | +2.9% | +23.1% | 3.54% | 11.36倍 | 0.53倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| 大幸薬品 | 40,700円 | +11.1% | - | 0.00% | 37.14倍 | 2.53倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| ステラファーマ | 53,800円 | +245.7% | - | 0.00% | - | 7.73倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
| ＰＲＩＳＭＢｉｏ | 44,400円 | +167.9% | - | 0.00% | - | 6.91倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
市場注目の銘柄
チャート関連のコラム
